Market Closed

SRZN
Surrozen
$ 31.61
-0.19%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Surrozen News

Latest Surrozen Stock News & SRZN Headlines

Head to Head Contrast: Surrozen (NASDAQ:SRZN) vs. Swedish Orphan Biovitrum (OTCMKTS:BIOVF)
a day ago | defenseworld.net
Surrozen Announces Pricing of $60 Million Underwritten Offering of Common Stock
2 days ago | globenewswire.com
Surrozen Reports Third Quarter 2026 Financial Results and Provides Business Update
5 days ago | globenewswire.com
Surrozen to Present at Upcoming Healthcare Investor Conference
8 days ago | globenewswire.com
Surrozen Announces Closing of Second Tranche of March 2025 Private Placement for $95.1 Million
25 days ago | globenewswire.com
Head to Head Review: Surrozen (NASDAQ:SRZN) and Prelude Therapeutics (NASDAQ:PRLD)
a month ago | defenseworld.net
Surrozen (NASDAQ:SRZN) & Whitehawk Therapeutics (NASDAQ:WHWK) Financial Comparison
a month ago | defenseworld.net
Surrozen Announces FDA Clearance of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema
a month ago | globenewswire.com
Surrozen Gains Momentum as FDA Submission Opens Path for Lead Therapy
2 months ago | benzinga.com
Surrozen, Inc. (SRZN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
2 months ago | seekingalpha.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

SRZN
Surrozen
$ 31.61
-0.19%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago